tiprankstipranks
Trending News
More News >
Recursion Pharmaceuticals, Inc (RXRX)
:RXRX
US Market

Recursion Pharmaceuticals (RXRX) Revenue

Compare
3,125 Followers

Recursion Pharmaceuticals Revenue

Recursion Pharmaceuticals had a revenue of 4.51M in the quarter ending Dec 31, 2024, with -82.70%. This bring the company's revenue in the last twelve months to 58.80M, Increased -9.79%. In the fiscal year ending Dec 31, 2024, Recursion Pharmaceuticals had annual revenue of 58.84M with 32.00% growth.
Revenue (ttm)
58.80M
Revenue Growth
32.00%
P/S Ratio
39.90
Revenue/Employee
$73,549
Employees
800
Market Cap
$2.35B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202458.84M14.26M+32.00%
Dec 31, 202344.58M4.89M+12.33%
Dec 31, 202239.68M29.68M+296.81%
Dec 31, 202110.00M6.59M+193.00%
Dec 31, 20203.41M1.70M+99.47%
Dec 31, 20191.71M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis